News

Keller Rohrback filed a class action lawsuit against Wells Fargo Bank alleging the bank victimized its customers by charging them for auto insurance that they did not need.

Keller Rohrback is investigating reports that Wells Fargo charged auto loan borrowers millions of dollars for insurance they did not need.

As the price of EpiPen products continues to sky-rocket, a number of state legislatures have begun to take matters into their own hands.

On July 19, 2017, consumer and reseller dealer plaintiffs filed a Consolidated Class Action Complaint (link to document) in the Northern District of California.

On July 8, 2017 the federal court overseeing the first class action lawsuit filed against Wells Fargo related to unauthorized accounts granted preliminary approval to a $142 million settlement designed to compensate Wells Fargo customers nationwide.

Michael Woerner and a team of attorneys, are investigating cases involving patients who took Invokana, Invokamet, or Invokamet XR and suffered an amputation as a result.

The cases seek to make the care and treatment for Type 1 and Type 2 Diabetes Patients more affordable and increase pricing transparency in the pharmaceutical industry.

Details have come to light about a conspiracy among manufacturers of automobile door locking mechanisms that has had the effect of raising the price of that vital component and hence of any car that includes one of those latches.

Keller Rohrback is investigating the increased risk of leg and foot amputations when taking the SGLT2 inhibitors: Invokana, Invokamet, Invokamet XR for the treatment of type 2 diabetes.